News & Announcements
Read the latest news from the Les Turner ALS Center at Northwestern University Feinberg School of Medicine. The links below take you to articles where you can learn more about our members' latest achievements, awards and honors.
Take A Breath featuring John M. Coleman III, MD, Associate Professor, Division of Pulmonary & Critical Care Medicine and Department of Neurology at Northwestern Medicine. Thursday, May 20 at 12 p.m. CST. Visit ALSLearningSeries.org to register.
There are several initiatives taking place throughout May to support those living with ALS, including fundraising opportunities and educational programs. Visit lesturnerals.org/breath.
An experimental drug called ezogabine reduced spinal neuron excitability in patients with ALS, according to a recent study.
The 10th Annual Les Turner Symposium on ALS — the first held virtually — featured scientific presentations, updates on innovative clinical trials and a question-and-answer session for patients and caretakers.
Northwestern Medicine scientists have discovered that mutations in the largest genetic contributor to ALS leads to the dysfunction and eventual degeneration of certain specialized subtypes in the brain. The findings may lead to development of novel therapeutic interventions for the disease.
Faculty, staff, students and trainees gathered for the ninth annual Les Turner Symposium on ALS and NeuroRepair, a one-day event highlighting the present and future of treating ALS.
Evangelos Kiskinis, PhD, has received a New York Stem Cell Foundation – Robertson Investigator Award to study the origins of ALS and pediatric epilepsy.
Two Northwestern University scientists have received a $3.1 million grant from the National Institute on Aging to collaborate and investigate drug therapies for amyotrophic lateral sclerosis (ALS).
Northwestern scientists have discovered how certain genetic mutations can weaken protein “quality control,” identifying a pathway that may contribute to neurodegenerative diseases.
The 8th Annual Les Turner Symposium brought together investigators, clinicians, patients and families to share the latest discoveries in ALS research, promote scientific collaboration and provide patient education.
Robert Kalb is moving Northwestern’s Les Turner ALS Center forward. Read the story in Northwestern Medicine magazine.
Basic Science conducted by investigators at Northwestern’s Les Turner ALS Center is building a foundation for future ALS care.
Robert Kalb, MD, Director of the Les Turner ALS Center at Northwestern Medicine is optimistic that more breakthroughs in the basic biology of the disease are on the way and a cure is possible.
Northwestern Medicine scientists used an innovative technique to measure electrical activity in ALS neurons, finding changes in excitability that indicated disease, according to a study published in Stem Cell Reports.
Northwestern Medicine scientists have uncovered how DNA methylation triggers stem cells to transform into more specialized neuronal cells.
The 7th Annual Les Turner Symposium showcased the integration of ALS investigation and clinical care at Northwestern Medicine and the Les Turner ALS Foundation.
Robert Kalb, MD, has been named to lead the Les Turner ALS Research and Patient Center at Northwestern Medicine, as the center’s inaugural director.
The major features of Parkinson’s disease have been linked to a toxic cascade beginning with oxidized dopamine, providing a possible therapeutic pathway.
A new review, published in Nature Reviews Neurology, outlines how upper motor neuron degeneration is an important feature in ALS pathology, and could be key to developing better diagnostic tools and treatments for ALS.
“Truly, Northwestern University Feinberg School of Medicine is an institution on the rise,” said Eric G. Neilson, MD, vice president for Medical Affairs and Lewis Landsberg Dean. See some of the medical school's notable moments from 2016.
- Les Turner ALS Symposium Gathers Scientists, Patients and Experts to Celebrate Research, Patient Care and Education11.10.2016
Physicians, patients, scientists and supporters gathered at the 6th Annual Les Turner Symposium on ALS and NeuroRepair to share research updates, provide patient education and foster new scientific collaborations.
Mutations in a gene called TMEM230 were definitively linked to confirmed cases of the common movement disorder in a recent Northwestern Medicine study.
Scientists showed that it is possible to specifically modify gene expression in diseased upper motor neurons in a new Northwestern Medicine translational study.
From the junctions that hold cells together to the bacteria that cause pneumonia, fascinating scientific images provide a window into the wide range of research that Feinberg faculty, trainees and students published in 2015.
The Fifth Annual Les Turner Symposium on ALS and NeuroRepair celebrated a new research and clinical care center and featured a variety of presentations, a keynote lecture and a poster session.
- Les Turner ALS Research and Patient Center at Northwestern Medicine to Unveil Ice Sculpture Exhibition to Bring Attention to ALS05.05.2015
The Les Turner ALS Research and Patient Center at Northwestern Medicine has commissioned an ice sculpture exhibition to bring attention to specific people with ALS and the debilitating effects of the disease.
Evangelos Kiskinis, PhD, assistant professor in Neurology and Physiology, uses stem cells to study the motor neurons and genes implicated in ALS.
Northwestern Medicine scientists have created and transplanted an artificial ovarian system that induced puberty in mouse models, a first step toward a new approach to improving fertility in childhood cancer survivors.
Northwestern Medicine scientists have revealed a mechanism underlying the cellular degeneration of the upper motor neurons that die in ALS, and developed a model system that will allow further research on the degeneration.